Clinical Trials GPS

Paid Arthritis Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with Active Psoriatic Arthritis Age 18 - 75

Avail is conducting a randomized, vehicle-controlled study to evaluate the safety and efficacy of a advanced form of rectal suppositories in the treatment of adult subjects with symptomatic internal hemorrhoids.

Avail is conducting a randomized, multi-center study of the pharmacodynamics, pharmacokinetics, and tolerability of a new liquid form drug in adult patients with chronic idiopathic constipation.

Achieve is conducting a safety and efficacy study on a new combination asthma treatment versus an inhaled treatment for adolescents and adult patients with asthma.

While government health sites remain behind the times, Clinical Trials GPS provides patients with up to date trial and facility data, new patient dashboard and study promotion tools for research sites.

Achieve is conducting a randomized, single-dose study comparing the efficacy and safety of a combination of acetaminophen and aspirin vs placebo in the acute treatment of migraine headaches.

Achieve is conducting a study to evaluate the safety and efficacy of a new drug versus rituximab in patients with moderately to severely active rheumatoid arthritis (RA).

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug for the treatment of opioid-induced constipation in adults taking opioid therapy for chronic non-cancer pain.

Avail is conducting a randomized, Phase 3 study comparing the efficacy and safety of a new psoriasis drug with Etanercept and a placebo in patients with moderate-to-severe moderate-to-severe plaque psoriasis.